Related Experiment Video

Updated: Jul 19, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Anti-VEGF therapy: a new approach to colorectal cancer therapy

Alfredo Carrato1, Javier Gallego-Plazas, Carmen Guillen-Ponce

  • 1Medical Oncology Service, Elche University Hospital, Department of Medicine, Miguel Hernandez University, Camino de la Almazara 11, Elche, 03203 Alicante, Spain. acarrato@telefonica.net

Expert Review of Anticancer Therapy
|October 31, 2006
PubMed

Insights

Targeting vascular endothelial growth factor (VEGF) inhibits tumor growth in advanced colorectal cancer. This review examines anti-VEGF agents, clinical trials, and future directions for this targeted therapy.

Area of Science:

  • Oncology
  • Cancer Research
  • Translational Medicine

Background:

  • Colorectal cancer remains a significant global health challenge.
  • Tumor angiogenesis, driven by vascular endothelial growth factor (VEGF), is crucial for advanced cancer progression.
  • Targeted therapies offer new avenues for treating advanced colorectal cancer.

Purpose of the Study:

  • To review the role of vascular endothelial growth factor (VEGF) inhibition in advanced colorectal cancer treatment.
  • To summarize the mechanisms of anti-VEGF therapy and its impact on tumor angiogenesis.
  • To discuss current clinical trials and future prospects of anti-VEGF agents.

Main Methods:

  • Literature review of preclinical studies and clinical trials.
  • Analysis of data from major clinical trials involving anti-VEGF agents.
  • Commentary on ongoing research and development of targeted therapies.

Main Results:

  • Vascular endothelial growth factor (VEGF) inhibition disrupts tumor blood vessel formation.
  • Clinical trials demonstrate varying efficacy of anti-VEGF agents in advanced colorectal cancer.
  • Several anti-VEGF agents are approved or in development for colorectal cancer treatment.

Conclusions:

  • Anti-VEGF therapy is a key strategy in managing advanced colorectal cancer.
  • Further research is needed to optimize patient selection and treatment regimens.
  • Future directions include combination therapies and novel anti-VEGF agents.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.